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INVESTIGATION AND MANAGEMENT OF A CLUSTER OF TB INFECTION IN A
NURSING HOME
Yuan-Hsin Chu a, Ya-Chi Huang a, Hsiao-Fang Cheng a, Yuen-Chun Hsu a,
Fang-Ching Liu b, Yi-Ching Huang b. aDepartment of Infection Control, Jen-
Ai Hospital, Taiwan; bDivision of Infectious Disease, Jen-Ai Hospital, Taiwan
Purpose: Tuberculosis (TB) in the nursing home is an increasing problem in
Taiwan. Detecting and diagnosing TB is challenging as the manifestations
are not obvious in elders. Along with the growing elders’ population and
the increase of long-term care facilities, more emphasis should be placed
on TB detection and prevention.
Methods: March 2012, in midland of Taiwan, two nursing home residents
persistently coughed and their sputum samples were collected and cultured.
Six weeks later, both residents were reported Mycobacterium tuberculosis
and were diagnosed TB. The doctor subsequently informed the Centers for
Disease Control (CDC) following the mandatory communicable disease pro-
cedure. We found the infected residents lived next door at the same floor
of the nursing home, thus the possibility of TB cluster can’t be excluded.
The infection control measures were immediately taken as follows: 1. Trans-
ferring both residents to isolated hospital wards and accepted the anti-TB
drug treatment. 2. Listing the list of contact persons including 36 residents
and 19 health care workers, and arrange them to take the chest X-ray. 3.
Sending their sputum samples to CDC and make a genotyping matching.
Results: May 5 2012, the results of genotyping matching by CDC showed the
two TB strains were different illustrated it is not a TB cluster in the nursing
home. And all contacts were normal.
Conclusions: Advices were made after discussion of this incident such as: 1.
Providing the report of chest X-ray within 3 month before moving to long-
term care facilities. 2. Educating lessons of TB prevention, and remind the
health care workers take the residents to OPD when they had the symptoms
of cough over 5 days. 3. Always wear mask during working. 4. All residents
and health care workers should take annual chest X-ray examination.PS 2-528
USE IMMEDIATELY ALARM SYSTEM TO FOLLOW UP THE TUBERCULOSIS
PATIENTS AFTER ANTI-TB MEDICATIONS TREATMENT
Hui-Chin Lin a, Shyh-Ren Chiang b, Ying-Ling Chen a, Chi-Fen Taou a, Hung-
Jen Tang b. aInfection Control Committee, Chi Mei Medical Center, Taiwan;
bDepartment of Internal Medicine, Chi Mei Medical Center, Taiwan
Background: TB patients may develop fatal adverse reactions after anti-TB
medications treatment. The TB treatment guideline, published from Taiwan
CDC, suggests that TB patients should receive blood biochemical test to
avoid these adverse responses. However, these data delayed to be notified
frequently by routine reported systems.
Objective: To evaluate whether a new reported system, immediately infor-
mation alarm system, for abnormal laboratory data to prevent side effects in
TB treatment.
Methods: The immediately information alarm system included these compo-
nents; 1. TB patients must receive GOT, GPT, total bilirubin, direct bilirubin,
creatine, uric acid and complete blood cell count before the TB treatment
and in 2nd, 4th, and 8th week after treatment. 2. At outpatient department,
TB patients, without any one of the clamed data within 7 days, the informa-
tion system would automatically show up those items for examination. 3.
The abnormal test data were notified by short message to physicians and
TB case managers immediately. 4. The physicians would evaluate these
data to avoid side effects and the case manager would contact the TB pa-
tient for medical education.
Results: From March 1, 2013 to February 28, 2014, 161 TB patients with 504
abnormal test data were notified by short message to physicians and TB case
managers immediately; included 204 (40.5%) abnormal renal function test,
84 (17.5%) abnormal liver function test, and 84 (16.7%) abnormal uric acid
data. Among these patients, total 43 patients (26.7%) with 24 abnormal
uric acid (56%), liver dysfunction, 16 (37%), and renal dysfunction 3 (7%)
were informed immediately to adjust the anti-TB medications.
Conclusion: Forty-three patients (26.7%) were informed via this immedi-
ately alarm system to prevent fatal outcome. This system may benefit to
TB patients to reduce side effects after treatment effectively and complete
the treatment course for TB patients.PS 2-529
COMPARISON OF THE INCIDENCE OF ADVERSE EVENTS AT THE
DIFFERENT PERIODS OF ANTI-TUBERCULOSIS TREATMENT IN A REGIONAL
HOSPITAL IN SOUTH TAIWAN
Miao-Jung Jian a, Meng-Hsuan Cheng b, Cheng-Yu Kuo c,d. aDepartment of
Nursing, Pingtung Hospital, Ministry of Health and Welfare, Pingtung,
Taiwan; bDivision of Pulmonary and Critical Care Medicine, Department of
Internal Medicine, Kaohsiung Medical University, Chung-Ho Memorial
Hospital, Kaohsiung, Taiwan; cDepartment of Internal Medicine, Pingtung
Hospital, Ministry of Health and Welfare, Pingtung, Taiwan; dDivision of
Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical
University, Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
Purpose: The side effects of anti-tuberculosis drugs are not uncommon in
patients with tuberculosis (TB). Furthermore, anti-TB treatment will last
at least six months. The adverse events (AEs) may occur at any time during
the course of anti-TB treatment. However, there are few studies about the
most likely time that AEs happen. Thus, we analyze the incidence of AEs
among the different periods of anti-TB treatment.
Methods: We conducted a study from January 1, 2013 to December 31, 2013
in a regional hospital in South Taiwan. We retrospectively collected AEs dur-
ing the course of anti-TB treatment. The patients with pulmonary or extrap-
ulmonary TB were included except multiple-drug-resistant TB. We divided
the duration of anti-TB treatment into five periods. These five periods
were the durations of the first week, the second week, from the third
week to the fourth week, from the fifth week to 60th day and from 61th
day to the day of complete treatment, respectively. We calculated the inci-
dence of AEs at these five periods.
Results: Eighty-three patients were eligible in this study. The incidence of AEs
was 48.2% during the complete course of anti-TB treatment. The highest inci-
dence of AEs among these five periods occurred in the third period (25.3%).
There was no significant difference in the incidence of AEs between the pa-
tients older than 65 and 65 or younger. The incidence of AEs didn’t significantly
differ between the patients with pulmonary TB and extrapulmonary TB.
Conclusions: This study showed that the highest incidence of AEs occurred
at the period of the third week and the fourth week. Although AEs may occur
at any time during the course of anti-TB treatment, we should take more
care of the patients taking anti-TB drugs in this period.PS 2-530
SERIAL TESTING OF INTERFERON-GAMMA RELEASE ASSAY FOR
DIAGNOSIS OF TUBERCULOSIS IN HIV-INFECTED ADULTS
Susan S. J. Lee a,b, Hsi-Hsun Lin c, Hung-Chin Tsai a,b, Kuan-Sheng Wu a,b,
Cheng-Len Sy a, Jui-Kuang Chen a, Yu-Ting Tseng a, Wan-Ting Hung a,
Yao-Shen Chen a,b. aSection of Infectious Diseases, Department of Internal
Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan;
bFaculty of Medicine, School of Medicine, National Yang-Ming University,
Taipei, Taiwan; cDepartment of Infection Control and Internal Medicine, E-
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Purpose: To determine the usefulness of interferon-gamma release assay
(IGRA) in serial testing for predicting development of active tuberculosis
in HIV-infected adults.
Methods: A prospective, cohort study enrolled HIV-infected adults in one
medical center and one regional hospital in Southern Taiwan. Quanti-
FERON-TB Gold (QFT,NZ802) and in-tube test (QFT-IT, NZ303) was done
at baseline and serial testing performed at 6-12 months intervals using
QFT in 310, and QFT-IT in 68 subjects.
Results: 927 HIV-infected adults entered the study, 892 men and 35 women,
with a mean age of 36.9 years (range 20.0-77.2years), including men-who-
have-sex-with-men (27.9%), heterosexual (9.3%) and intravenous drug users
(61.8%). The median CD4 count was 473 cells/uL, with 6.8% CD4<200, and
73.6% CD4>Z350. The median log HIV viral load was 3.46 copies/mL, and viral
suppression was achieved in 60.0% and 72.7% of MSMs and heterosexuals,
respectively, and 5.3% in IDUs due to differential uptake of antiretrovirals.
Lower CD4 cell counts (<200cells/uL) affected the performance of QFTresulting
in lower positive rates and higher indeterminate rates (10.9%), but not QFT-IT.
QFT conversion occurred in 19 (6.1%) and reversion in 32 (10.3%). QFT-IT
conversion was found in 4 (5.9%) and reversions in 3 (4.4%). The conversion
rate of QFT and QFT-IT was 0.429 and 0.343 per 100 person-months,
respectively. The study subjects were followed up for a median of 7.23
